B. P. BIOTRANSPORT ApS FØVLING

 

Quicksearch
from your own companies




Analyst: XBRLDenmark
 
Loading...

Loading...

Loading...

Loading...

 
Loading...

Bankruptcy Risk 
2020
2020/9
2021
2021/9
2022
2022/9
2023
2023/9
2024
2024/9
Bankruptcy risk for industry  5.7% 5.7% 5.7% 5.7% 5.7%  
Bankruptcy risk  4.3% 6.8% 5.1% 4.1% 8.0%  
Credit score (0-100)  48 34 42 48 30  
Credit rating  BBB BBB BBB BBB BB  
Credit limit (kDKK)  0.0 0.0 0.0 0.0 0.0  

How are these values calculated?
 
View the automatically generated explanation of bankruptcy risk

Income statement (kDKK) 
2020
2020/9
2021
2021/9
2022
2022/9
2023
2023/9
2024
2024/9

Net sales  0 0 0 0 0  
Gross profit  730 748 895 710 541  
EBITDA  52.0 91.1 253 197 -222  
EBIT  20.6 -58.8 243 188 -233  
Pre-tax profit (PTP)  20.5 -142.8 203.8 148.8 -273.3  
Net earnings  16.0 -138.3 158.5 115.3 -271.6  
Pre-tax profit without non-rec. items  20.5 -143 204 149 -273  

 
See the entire income statement

Balance sheet (kDKK) 
2020
2020/9
2021
2021/9
2022
2022/9
2023
2023/9
2024
2024/9

Tangible assets total  221 14.9 12.4 7.6 2.8  
Shareholders equity total  460 272 431 546 274  
Interest-bearing liabilities  10.6 12.3 39.4 39.5 36.2  
Balance sheet total (assets)  767 484 694 787 482  

Net Debt  -273 -243 -334 -298 -50.3  
 
See the entire balance sheet

Volume 
2020
2020/9
2021
2021/9
2022
2022/9
2023
2023/9
2024
2024/9

Net sales  0 0 0 0 0  
Net sales growth  0.0% 0.0% 0.0% 0.0% 0.0%  
Gross profit  730 748 895 710 541  
Gross profit growth  -27.5% 2.5% 19.7% -20.7% -23.7%  
Employees  2 2 2 1 1  
Employee growth %  -33.3% 0.0% 0.0% -50.0% 0.0%  
Employee expenses  0.0 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  767 484 694 787 482  
Balance sheet change%  12.4% -36.9% 43.3% 13.4% -38.8%  
Added value  52.0 91.1 253.5 198.6 -222.4  
Added value %  0.0% 0.0% 0.0% 0.0% 0.0%  
Investments  -29 -356 -13 -13 -16  

Net sales trend  0.0 0.0 0.0 0.0 0.0  
EBIT trend  2.0 -1.0 1.0 2.0 -1.0  

Profitability 
2020
2020/9
2021
2021/9
2022
2022/9
2023
2023/9
2024
2024/9
EBITDA %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT to gross profit (%)  2.8% -7.9% 27.2% 26.5% -43.1%  
Net Earnings %  0.0% 0.0% 0.0% 0.0% 0.0%  
Profit before depreciation and extraordinary items %  0.0% 0.0% 0.0% 0.0% 0.0%  
Pre tax profit less extraordinaries %  0.0% 0.0% 0.0% 0.0% 0.0%  
ROA %  2.8% -9.4% 41.3% 25.4% -36.8%  
ROI %  4.4% -15.6% 64.2% 35.5% -52.0%  
ROE %  3.5% -37.8% 45.1% 23.6% -66.2%  

Solidity 
2020
2020/9
2021
2021/9
2022
2022/9
2023
2023/9
2024
2024/9
Equity ratio %  60.0% 56.2% 62.1% 69.4% 56.9%  
Relative indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Relative net indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net int. bear. debt to EBITDA, %  -524.3% -266.9% -131.9% -151.3% 22.6%  
Gearing %  2.3% 4.5% 9.1% 7.2% 13.2%  
Net interest  0 0 0 0 0  
Financing costs %  0.1% 731.1% 151.9% 99.8% 105.4%  

Liquidity 
2020
2020/9
2021
2021/9
2022
2022/9
2023
2023/9
2024
2024/9
Quick Ratio  1.8 2.2 2.6 3.3 2.3  
Current Ratio  1.8 2.2 2.6 3.3 2.3  
Cash and cash equivalent  283.3 255.5 373.8 337.1 86.5  

Capital use efficiency 
2020
2020/9
2021
2021/9
2022
2022/9
2023
2023/9
2024
2024/9
Trade debtors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Trade creditors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Current assets / Net sales %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net working capital  239.5 257.1 420.8 539.9 271.4  
Net working capital %  0.0% 0.0% 0.0% 0.0% 0.0%  

Employee efficiency 
2020
2020/9
2021
2021/9
2022
2022/9
2023
2023/9
2024
2024/9
Net sales / employee  0 0 0 0 0  
Added value / employee  26 46 127 199 -222  
Employee expenses / employee  0 0 0 0 0  
EBITDA / employee  26 46 127 197 -222  
EBIT / employee  10 -29 122 188 -233  
Net earnings / employee  8 -69 79 115 -272